APA (7th ed.) Citation

Tao Liu, Jin Shu, Yangchun Liu, Jian Xie, Tao Li, Haoliang Li, . . . Lang Li. (2022). Atorvastatin attenuates ferroptosis-dependent myocardial injury and inflammation following coronary microembolization via the Hif1a/Ptgs2 pathway. Frontiers Media S.A..

Chicago Style (17th ed.) Citation

Tao Liu, Jin Shu, Yangchun Liu, Jian Xie, Tao Li, Haoliang Li, Lang Li, and Lang Li. Atorvastatin Attenuates Ferroptosis-dependent Myocardial Injury and Inflammation Following Coronary Microembolization via the Hif1a/Ptgs2 Pathway. Frontiers Media S.A., 2022.

MLA (9th ed.) Citation

Tao Liu, et al. Atorvastatin Attenuates Ferroptosis-dependent Myocardial Injury and Inflammation Following Coronary Microembolization via the Hif1a/Ptgs2 Pathway. Frontiers Media S.A., 2022.